Literature DB >> 15578503

How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity.

Laura C Seeff1, Thomas B Richards, Jean A Shapiro, Marion R Nadel, Diane L Manninen, Leslie S Given, Fred B Dong, Linda D Winges, Matthew T McKenna.   

Abstract

BACKGROUND & AIMS: Estimates of the current number of endoscopic colorectal cancer screening and follow-up examinations being performed are limited. A national study was therefore conducted among US physician practices.
METHODS: Approximately 1800 medical practices were surveyed from a list of all practices known to have purchased or leased lower endoscopic equipment between 1996 and 2000. Questions were asked regarding the current number of lower endoscopic procedures performed and the potential maximum number that could be performed.
RESULTS: In 2002, a total of 8207 practices reported performing flexible sigmoidoscopy or colonoscopy in the United States. Gastroenterologists performed 43.7% (95% confidence interval [CI], 37.2-50.2) of all sigmoidoscopies and 82.5% (95% CI, 80.3-84.7) of all colonoscopies. Primary care physicians performed 24.9% (95% CI, 20.3-29.5) of all sigmoidoscopies and 2.0% (95% CI, 1.4-2.6) of all colonoscopies. All physicians combined performed approximately 2.8 million (95% CI, 2.4-3.1) flexible sigmoidoscopies and 14.2 million (95% CI, 12.1-16.4) colonoscopies but reported that they could increase to approximately 9.5 million flexible sigmoidoscopies (95% CI, 8.4-10.5) and 22.4 million colonoscopies (95% CI, 20.1-24.8) in 1 year.
CONCLUSIONS: Approximately 2.8 million flexible sigmoidoscopies and 14.2 million colonoscopies were estimated to have been performed in 2002. Physicians reported that they could perform an additional 6.7 million flexible sigmoidoscopies and 8.2 million colonoscopies in 1 year. These additional procedures could be used for the unscreened population and should be considered in the estimate of the national capacity to provide colorectal cancer screening to all eligible persons in the United States.

Entities:  

Mesh:

Year:  2004        PMID: 15578503     DOI: 10.1053/j.gastro.2004.09.051

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  142 in total

1.  Splenic rupture: a case of massive hemoperitoneum following therapeutic colonoscopy.

Authors:  Daniel Murariu; Sarah Takekawa; Nancy Furumoto
Journal:  Hawaii Med J       Date:  2010-06

2.  Seeking the ultimate bowel preparation for colonoscopy: is the end in sight?

Authors:  Robert Jay Hilsden
Journal:  Can J Gastroenterol       Date:  2011-12       Impact factor: 3.522

Review 3.  Risks versus benefits of gastrointestinal endoscopy during pregnancy.

Authors:  Mitchell S Cappell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-04       Impact factor: 46.802

4.  Outcomes research in gastroenterology and endoscopy.

Authors:  Parantap Gupta; Jonathan M Buscaglia
Journal:  World J Gastrointest Endosc       Date:  2012-06-16

5.  Pitfalls of using administrative data for research.

Authors:  David Lieberman
Journal:  Dig Dis Sci       Date:  2010-06       Impact factor: 3.199

6.  Virtual colonoscopy vs optical colonoscopy.

Authors:  Zhengrong Liang; Robert Richards
Journal:  Expert Opin Med Diagn       Date:  2010-03-01

7.  Ascertainment of colonoscopy indication using administrative data.

Authors:  Deborah A Fisher; Janet M Grubber; John M Castor; Cynthia J Coffman
Journal:  Dig Dis Sci       Date:  2010-06       Impact factor: 3.199

8.  Physician characteristics associated with higher adenoma detection rate.

Authors:  Ateev Mehrotra; Michele Morris; Rebecca A Gourevitch; David S Carrell; Daniel A Leffler; Sherri Rose; Julia B Greer; Seth D Crockett; Andrew Baer; Robert E Schoen
Journal:  Gastrointest Endosc       Date:  2017-09-01       Impact factor: 9.427

9.  Predictors of suboptimal bowel preparation in asymptomatic patients undergoing average-risk screening colonoscopy.

Authors:  Shail M Govani; Eric E Elliott; Stacy B Menees; Stephanie L Judd; Sameer D Saini; Constantinos P Anastassiades; Annette L Urganus; Suzanna J Boyce; Philip S Schoenfeld
Journal:  World J Gastrointest Endosc       Date:  2016-09-16

10.  Split dose and MiraLAX-based purgatives to enhance bowel preparation quality becoming common recommendations in the US.

Authors:  Grace Clarke Hillyer; Benjamin Lebwohl; Corey H Basch; Charles E Basch; Fay Kastrinos; Beverly J Insel; Alfred I Neugut
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.